Insider filing · CRSP
Raju Prasad
Chief Financial Officer
profile →
CRISPR Therapeutics AG
CRSP · Healthcare · 34 filings in 24 months
ticker →
Raju Prasad sold $503K of CRISPR Therapeutics AG (CRSP)
Executed Dec 22 2025, disclosed Dec 23 2025, 1 day later.
Value, as filed
$503K
9,000 sh across 2 lots
Executed
Dec 22 2025
the trade date, as filed
Disclosed
Dec 23 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RPRaju Prasad (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $2.1M of CRSP (34,972 sh × $60.19, as filed), executed Jan 22.
The name
CRSPHealthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Raju Prasad in CRSP
CRSPSALE
CRISPR Therapeutics AG
$173K3,708 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $476K
9,869 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $2.1M
34,972 sh × $60.19
Exec Jan 22
Filed Jan 26 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $1.8M
29,700 sh across 3 lots
Exec Jan 6
Filed Jan 8 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $157K
3,762 sh × $41.80
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET